The chemical class known as HEATR1 Inhibitors comprises a diverse group of compounds designed to modulate the function of the HEAT Repeat Containing 1 (HEATR1) protein. HEATR1, characterized by its HEAT repeats - motifs facilitating protein-protein interactions - plays a pivotal role in various cellular processes, including signal transduction, intracellular transport, and possibly gene regulation. The inhibitors in this class are not direct antagonists of the protein. Instead, they operate by influencing the broader cellular pathways and processes in which HEATR1 is involved. This indirect approach to modulation reflects the complex nature of targeting proteins like HEATR1, which do not have a traditional enzymatic activity or a well-defined ligand-binding pocket, making them less amenable to direct inhibition.
These inhibitors encompass compounds that target a range of cellular mechanisms and pathways. Some focus on altering signal transduction pathways, crucial for various cell functions and likely involving HEATR1. By modulating these pathways, these compounds can alter the cellular context in which HEATR1 operates, thereby influencing its activity. Other compounds in this class target the cellular transport mechanisms and cytoskeletal organization. Since HEATR1 might be involved in intracellular transport processes, modulating these pathways can affect its function. Additionally, some compounds aim at modulating gene expression and chromatin structure, indirectly affecting HEATR1's role in gene regulation. This approach is particularly relevant given the involvement of HEATR1 in chromatin remodeling processes. Moreover, the class includes compounds that target stress response pathways and protein degradation systems. These pathways are essential for maintaining cellular homeostasis and are likely to intersect with HEATR1's functions. By influencing the cell's response to stress or the stability of proteins, these compounds can modulate the overall environment in which HEATR1 operates. The diversity of these compounds underscores the multifunctional nature of HEATR1 and reflects the complexity of cellular signaling networks. The approach to inhibiting HEATR1, thus, requires a sophisticated understanding of the intricate interplay between different cellular components and pathways. The modulation of HEATR1 through these various mechanisms highlights not only the complexity of targeting such a protein but also the nuanced understanding required to affect its function within the dense network of cellular interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This HDAC-targeting compound could possibly inhibit HEATR1 by altering gene expression, potentially affecting its role in chromatin remodeling or gene regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a PI3K-targeting compound, it could possibly inhibit HEATR1 by influencing signal transduction pathways, thereby affecting its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR-targeting compound could possibly inhibit HEATR1 by impacting cellular growth and metabolism pathways, influencing HEATR1's role in these processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK-targeting compound that could possibly inhibit HEATR1 by affecting cytoskeletal organization and cellular transport, where HEATR1 might be involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By targeting p38 MAPK, this compound could possibly inhibit HEATR1 by modifying stress response pathways, influencing its function in these processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Targeting MEK in the MAPK/ERK pathway, this compound could possibly inhibit HEATR1 by affecting cellular processes where it is implicated. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome-targeting compound could possibly inhibit HEATR1 by affecting protein degradation pathways, impacting its function or stability. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Targeting JNK in the MAPK signaling pathway, this compound could possibly inhibit HEATR1 by intersecting with cellular stress responses. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase-targeting compound that could possibly inhibit HEATR1 by affecting cell cycle regulation, influencing processes where it is involved. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule stabilizer that could possibly inhibit HEATR1 by affecting intracellular transport and cytoskeletal organization | ||||||